Is Peanut Butter Good for Fatty Liver?

Peanut butter and fatty liver disease is a common dietary question, and the short answer is reassuring: peanut butter is unlikely to harm the liver and may offer modest benefits when eaten in moderation as part of a balanced diet. Fatty liver disease, or metabolic dysfunction-associated steatotic liver disease (MASLD), is closely linked to diet, weight and metabolic health. Peanut butter provides monounsaturated fats, plant-based protein, fibre and vitamin E, all of which support liver-friendly eating patterns endorsed by NHS and NICE guidance. Portion control and overall diet quality remain the most important factors.

Is peanut butter good for fatty liver disease?

Peanut butter is unlikely to harm a fatty liver and may offer modest benefits due to its unsaturated fats, fibre and plant protein, but moderation within a calorie-controlled diet is essential, as it is not a standalone treatment.

Peanut butter is unlikely to harm a fatty liver and may offer modest benefits as part of a balanced, calorie-controlled diet, though it is not a treatment for the condition. Fatty liver disease, known medically as metabolic dysfunction-associated steatotic liver disease (MASLD, previously called non-alcoholic fatty liver disease or NAFLD), or in its alcohol-related form as alcohol-related liver disease (ALD), involves an accumulation of fat within liver cells. Dietary choices play a central role in managing the condition, and NHS and NICE guidance (NICE guideline NG49) supports a dietary pattern rich in unsaturated fats, fibre and plant-based protein as part of a broader lifestyle approach.^[1][2]

Peanut butter contains predominantly monounsaturated and polyunsaturated fatty acids, which are considered more liver-friendly than saturated fats. It also provides plant-based protein, dietary fibre, vitamin E and magnesium. These nutrients are associated with reduced inflammation and improved insulin sensitivity, both of which are relevant to MASLD, since the condition is closely linked to obesity, type 2 diabetes and metabolic syndrome. Any benefit, however, is likely to reflect the overall dietary pattern rather than peanut butter in isolation.

That said, peanut butter is energy-dense, and overconsumption can contribute to weight gain, which is one of the primary drivers of fatty liver progression. The key principle is moderation within an overall dietary pattern that supports a healthy weight. Peanut butter should be viewed as one component of a liver-supportive diet rather than a standalone remedy. Anyone with a confirmed diagnosis of fatty liver disease should discuss dietary changes with their GP or a registered dietitian, who can tailor advice to their individual circumstances.

What does the evidence say about peanuts and liver health?

Observational studies associate regular nut consumption with lower liver enzyme levels and reduced MASLD prevalence, but evidence cannot isolate peanuts specifically or confirm cause and effect.

Research suggests that regular nut consumption, including peanuts, is associated with a lower risk of MASLD and improved liver enzyme profiles, though most studies are observational and cannot confirm cause and effect. A number of epidemiological studies have found that people who eat nuts more frequently tend to have lower levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), which are liver enzymes that rise when the liver is under stress.^[4]

Peanuts are technically legumes rather than tree nuts, but they share a similar nutritional profile. They contain resveratrol, a polyphenol with antioxidant properties, and oleic acid, a monounsaturated fat that has been studied for its anti-inflammatory effects.^[9] It should be noted that resveratrol levels in peanuts are relatively low and the clinical significance for MASLD outcomes in humans has not been established. Some animal studies have shown that peanut-derived compounds can reduce hepatic fat accumulation, though translating these findings directly to human clinical outcomes requires caution.

A 2019 cohort study published in Liver International found that higher nut intake was inversely associated with the prevalence of MASLD in a large population sample.^[4] However, the study could not isolate peanuts specifically, and confounding factors such as overall diet quality and physical activity levels make it difficult to attribute any benefit to peanuts alone.

The broader evidence base supports a Mediterranean-style dietary pattern for liver health, within which nuts and nut butters feature prominently. NICE guideline NG49 emphasises weight management and dietary improvement as the cornerstone of MASLD management, and peanut butter can fit within this framework when consumed in appropriate quantities.

How much peanut butter is safe to eat with a fatty liver?

One to two tablespoons (approximately 15 to 40 grams) per day is a reasonable portion for most adults with fatty liver disease, provided it fits within overall calorie targets.

A portion of around one to two tablespoons (approximately 15 to 40 grams, as one UK tablespoon of peanut butter is typically around 15 to 20 grams) per day is a reasonable amount for most adults managing fatty liver disease, provided it fits within their overall calorie and macronutrient targets. There is no specific clinical guideline that sets a precise daily limit for peanut butter in the context of liver disease, so individual dietary advice from a registered dietitian remains the most reliable guide.

Because peanut butter is calorie-dense, containing roughly 580 to 620 kilocalories per 100 grams (based on standard UK nutrition data), portion control is important. For people with MASLD who are working towards weight loss, even modest reductions in body weight of 5 to 10 per cent have been shown to improve liver fat content and liver enzyme levels, according to NICE guideline NG49 and NHS guidance.^[1][3] Consuming peanut butter in excess of daily energy needs would counteract this goal.

When choosing peanut butter, it is advisable to select varieties with no added sugar, no added salt and no hydrogenated oils. Some commercial products contain palm oil or added sweeteners, which reduce their nutritional value. Whole-nut or natural peanut butters, where the only ingredient is peanuts, are generally preferable.

Peanut butter can be incorporated into meals in practical ways, such as spreading it on wholegrain toast, stirring it into porridge or using it as a dip for raw vegetables. These combinations also add fibre, which supports gut health and may indirectly benefit the liver. Anyone unsure about appropriate portion sizes should seek personalised advice from their GP or a dietitian.

Which foods and nutrients support a healthy liver?

A Mediterranean-style diet emphasising vegetables, wholegrains, oily fish, olive oil and nuts is the most consistently supported approach for improving liver health in MASLD, per NICE guideline NG49.

A Mediterranean-style dietary pattern is the most consistently supported approach for improving liver health in people with MASLD, according to NICE guideline NG49 and NHS guidance. This pattern emphasises vegetables, fruit, wholegrains, legumes, oily fish, olive oil and nuts, while limiting red and processed meat, refined carbohydrates, added sugars and saturated fats.

Several specific nutrients and foods have been studied in the context of liver health:

• Omega-3 fatty acids, found in oily fish such as salmon, mackerel and sardines, have been associated with possible reductions in liver fat and triglyceride levels in some studies. Effects on liver inflammation and histological outcomes remain less certain, and UK specialist guidelines (BSG/BASL) do not currently recommend omega-3 supplementation as a routine treatment for MASLD.

• Vitamin E, present in nuts, seeds and plant oils, has antioxidant properties and has been studied in MASLD. It is not routinely recommended in the UK and should only be considered under specialist supervision in selected cases, as advised by BSG/BASL guidance.

• Coffee, consumed without added sugar or cream, has been associated in multiple observational studies with lower rates of liver fibrosis and cirrhosis.^[10][11] The mechanism is not fully established and these findings are not yet reflected in formal UK clinical guidelines.

• Fibre-rich foods, including oats, pulses, vegetables and wholegrains, support gut microbiome health and may reduce hepatic fat accumulation.

• Olive oil, a cornerstone of the Mediterranean diet, contains oleocanthal and oleic acid, both of which have anti-inflammatory properties relevant to liver health.

Regarding alcohol, people with alcohol-related liver disease (ALD) are advised to abstain completely. For those with MASLD, UK Chief Medical Officers' low-risk drinking guidelines recommend keeping alcohol consumption to no more than 14 units per week, spread across several days, though reducing intake further is likely to be beneficial. Fructose-rich foods and drinks, particularly sugar-sweetened beverages, are strongly associated with hepatic fat accumulation and should be limited.^[5][6] Ultra-processed foods high in saturated fat and refined sugar are similarly discouraged. A registered dietitian can help individuals build a practical, sustainable eating plan that incorporates liver-supportive foods within their daily routine.

Are there any risks of eating peanut butter with liver disease?

The main risk is excess calorie intake leading to weight gain; aflatoxin contamination in UK commercial products is strictly regulated and considered safe, but advanced liver disease warrants specialist dietary guidance.

The main practical risk of eating peanut butter with fatty liver disease is its high calorie content. Because weight management is central to MASLD treatment, consuming peanut butter in excess of daily energy needs can contribute to weight gain and worsen liver fat accumulation. Portion control is therefore the most important consideration for most people.

Aflatoxin contamination is a separate, theoretical concern. Aflatoxins are naturally occurring mycotoxins produced by certain moulds that can grow on peanuts, and they are recognised hepatotoxins. In the UK, the Food Standards Agency (FSA) sets strict maximum limits for aflatoxins in peanut products, and commercially produced peanut butter from reputable UK manufacturers is routinely tested and considered safe for consumption. Homemade preparations or imported products from regions with less stringent food safety regulation may carry a higher risk, and these are best avoided.

For people with advanced liver disease, including cirrhosis or significant fibrosis, dietary protein requirements and tolerances may differ from those with early-stage MASLD. In some cases of severe hepatic encephalopathy, protein intake may need to be carefully managed, though current hepatology guidance generally supports adequate protein consumption rather than restriction. Anyone with advanced liver disease should follow the specific dietary advice of their hepatology team.

Peanut allergy is a separate consideration and is unrelated to liver disease. Peanut allergy is one of the most common food allergies in the UK, and reactions can be severe. Signs of a serious allergic reaction (anaphylaxis) include difficulty breathing, swelling of the throat or tongue, dizziness and collapse. If any of these occur, call 999 immediately. Individuals with a known peanut allergy should avoid peanut butter entirely.

Some peanut butter products contain added salt, which may be relevant for people with liver disease who are also managing hypertension or fluid retention. Choosing low-salt or no-added-salt varieties is advisable in these circumstances. If you have any concerns about how peanut butter fits into your diet alongside a liver condition, speak to your GP, who can refer you to a dietitian or specialist as appropriate.

If you experience symptoms such as yellowing of the skin or eyes (jaundice), confusion, vomiting blood, black or tarry stools, or rapid swelling of the abdomen, seek urgent medical attention or call 999, as these may indicate serious liver complications that require prompt assessment.

Scientific References

1. Non-alcoholic fatty liver disease (NAFLD): assessment and management (NG49).
2. Advice on physical activity, diet and alcohol | Liver disease (QS152).
3. Non-alcoholic fatty liver disease (NAFLD).
4. Association between nut consumption and non-alcoholic fatty liver disease in adults.
5. Important Food Sources of Fructose-Containing Sugars and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Controlled Trials.
6. Fructose and risk of cardiometabolic disease.
7. Current Update on Nomenclature, Diagnosis, and Management of Metabolic Dysfunction-associated Steatotic Liver Disease: Radiologists' Perspective.
8. EASL position paper on preclinical models of steatotic liver disease.
9. Resveratrol in peanuts.
10. Association between caffeine consumption and nonalcoholic fatty liver disease: a systemic review and meta-analysis.
11. Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: A systematic review and meta-analysis of observational studies.
12. Effect of Coffee Consumption on Non-Alcoholic Fatty Liver Disease.
13. Alcohol consumption: advice on low risk drinking – UK Chief Medical Officers.
14. Mycotoxins.
15. Low-protein diets for hepatic encephalopathy debunked: let them eat steak.
16. Dietary and nutritional indications in hepatic encephalopathy.
17. Nutritional Management in Cirrhosis and Hepatic Encephalopathy: Current Practices and Expert Opinions of Indian Gastroenterologists.
18. Omega-3 - BDA - British Dietetic Association.

Frequently Asked Questions